tiprankstipranks
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market

Neurosense Therapeutics Ltd. (NRSN) Stock Investors

65 Followers
Based on 726,024 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NRSN
On average, investors allocate 0.00% of their portfolios to NRSN
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NRSN

1.9%
Last 7
Days
4.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NRSN, out of 726,024 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NRSN Investor Activity

No data currently available
Based on the activity of 13,660 investors who made their portfolios public
The table shows changes in NRSN in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NRSN Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
4.87%
+1.14%
+1.88%
2.59B
Financial
Coinbase Global
8.47%
-0.44%
-1.49%
58.36B
Financial
Marathon Digital Holdings
5.56%
-0.08%
-2.27%
5.21B
Financial
DraftKings
7.15%
+0.10%
-1.65%
40.91B
Consumer Cyclical
ChargePoint Holdings
3.97%
-1.10%
-7.34%
774.75M
Consumer Cyclical
Airbnb
4.74%
-0.73%
-3.50%
104.71B
Consumer Cyclical
AMC Entertainment
5.38%
-0.66%
-6.65%
793.45M
Communication Services
Devon Energy
5.57%
-0.58%
-5.32%
33.83B
Energy
Plug Power
4.90%
-1.14%
-5.25%
2.15B
Industrials
Mastercard
4.82%
+0.17%
-1.36%
445.13B
Financial
Based on the activity of 726,024 active portfolios
Open your Smart Portfolio

NRSN Investor Analysis

NRSN investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of NRSN holders
are under 35
Average Segment Performance
Average P/E Ratio57.65
Beta6.67
Dividend Yield5.74%
NRSN investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
55.6%
of NRSN holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.43
Beta11.55
Dividend Yield15.66%
NRSN investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
33.3%
of NRSN holders
are over 55
Average Segment Performance
Average P/E Ratio53.87
Beta4.05
Dividend Yield5.57%
Overview of age group and performance of NRSN stock investors
See who invests in NRSN according to age group and performance.

FAQ

How many retail Investors hold NRSN?
<0.1% of TipRanks' retail investors hold NRSN in their portfolios.
    What is NRSN Investor Sentiment?
    NRSN’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of NRSN in the last 7 days?
      ▼ 1.9% of TipRanks' retail investors changed their holding of NRSN in the last 7 days.
        What percentage of retail investors changed their holding of NRSN in the last 30 days?
        ▼ 4.3% of TipRanks' retail investors changed their holding of NRSN in the last 30 days.
          What is the average age of retail investors who hold NRSN?
          The average age of NRSN Holders is between 35–55.
            What other stocks have NRSN investors also bought?
            NRSN Investors also bought RIOT, COIN, MARA, DKNG, CHPT, ABNB, AMC, DVN, PLUG, MA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              NOTVInotiv
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis